Literature DB >> 31970984

High-Affinity Interactions of the nSH3/cSH3 Domains of Grb2 with the C-Terminal Proline-Rich Domain of SOS1.

Tsung-Jen Liao1,2, Hyunbum Jang2, Ruth Nussinov2,3, David Fushman1,4.   

Abstract

Grb2 is an adaptor protein that recruits Ras-specific n class="Chemical">guanine nucleotide exchange factor, Son of Sevenless 1 (SOS1), to the plasma membrane. SOS1 exchanges GDP by GTP, activating Ras. Grb2 consists of an SH2 domain flanked by N- and C-terminal SH3 domains (nSH3/cSH3). Grb2 nSH3/cSH3 domains have strong binding affinity for the SOS1 proline-rich (PR) domain that mediates the Grb2-SOS1 interaction. The nSH3/cSH3 domains have distinct preferred binding motifs: PxxPxR for nSH3 and PxxxRxxKP for cSH3 (x represents any natural amino acid). Several nSH3-binding motifs have been identified in the SOS1 PR domain but none specific for cSH3 binding. Even though both nSH3 and cSH3 exhibit the strongest binding to the SOS1 peptide PVPPPVPPRRRP, this mutually exclusive binding combined with other potential nSH3/cSH3 binding regions in SOS1 makes understanding the Grb2-SOS1 interaction challenging. To identify the SOS1-cSH3 binding sites, we selected seven potential binding segments in SOS1. The synthesized peptides were tested for their binding to nSH3/cSH3. Our NMR data reveal that the PKLPPKTYKREH peptide has strong binding affinity for cSH3, but very weak for nSH3. The binding specificity suggests that the most likely Grb2-SOS1 binding mode is through nSH3-PVPPPVPPRRRP and cSH3-PKLPPKTYKREH interactions, which is supported by replica-exchange simulations for the Grb2-SOS1 complex models. We propose that nSH3/cSH3 binding peptides, which effectively interrupt Grb2-SOS1 association, can serve as tumor suppressors. The Grb2-SOS1 mechanism outlined here offers new venues for future therapeutic strategies for upstream mutations in cancer, such as in EGFR.

Entities:  

Year:  2020        PMID: 31970984     DOI: 10.1021/jacs.9b10710

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  10 in total

Review 1.  Inhibition of Nonfunctional Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Attila Gursoy; Ozlem Keskin; Vadim Gaponenko
Journal:  Cell Chem Biol       Date:  2021-01-12       Impact factor: 8.116

2.  The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia.

Authors:  Yonglan Liu; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Ryan Maloney; Ruth Nussinov
Journal:  Biophys J       Date:  2022-05-31       Impact factor: 3.699

3.  Allosteric regulation of GRB2 modulates RAS activation.

Authors:  Neda S Kazemein Jasemi; Mohammad R Ahmadian
Journal:  Small GTPases       Date:  2022-01

Review 4.  Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Yonglan Liu; Chung-Jung Tsai; Hyunbum Jang
Journal:  J Mol Biol       Date:  2022-04-01       Impact factor: 6.151

5.  SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations.

Authors:  Tsung-Jen Liao; Hyunbum Jang; David Fushman; Ruth Nussinov
Journal:  J Chem Phys       Date:  2020-07-28       Impact factor: 3.488

6.  Proline-rich domain of human ALIX contains multiple TSG101-UEV interaction sites and forms phosphorylation-mediated reversible amyloids.

Authors:  Ruben D Elias; Wen Ma; Rodolfo Ghirlando; Charles D Schwieters; Vijay S Reddy; Lalit Deshmukh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

7.  Neuroprotective Effects of ZiBuPiYin Recipe on db/db Mice via PI3K-Akt Signaling Pathway by Activating Grb2.

Authors:  Wei-Ming Ren; Ze-Bin Weng; Xin Li; Li-Bin Zhan
Journal:  Neural Plast       Date:  2021-01-30       Impact factor: 3.599

8.  Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect.

Authors:  Xuan He; Kui Du; Yuanhao Wang; Jigang Fan; Mingyu Li; Duan Ni; Shaoyong Lu; Xiaolan Bian; Yaqin Liu
Journal:  Front Mol Biosci       Date:  2022-04-08

9.  Allosteric regulation of autoinhibition and activation of c-Abl.

Authors:  Yonglan Liu; Mingzhen Zhang; Chung-Jung Tsai; Hyunbum Jang; Ruth Nussinov
Journal:  Comput Struct Biotechnol J       Date:  2022-08-11       Impact factor: 6.155

Review 10.  Mechanism of activation and the rewired network: New drug design concepts.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Chung-Jung Tsai; Bengi Ruken Yavuz; Nurcan Tuncbag; Hyunbum Jang
Journal:  Med Res Rev       Date:  2021-10-25       Impact factor: 12.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.